Curis (CRIS)

Add to Watchlists Create an Alert
1.70 +0.05  +3.03% NASDAQ Aug 19, 8:00PM BATS Real time Currency in USD
View Full Chart
CRIS Price Chart
View All Events

CRIS Events

Date Type Description
08/07/2014 09:00 EDT Misc Q2 2014 Curis Inc Earnings Conference Call
08/07/2014 Earnings Curis Inc 2Q2014 Earning Result
05/21/2014 Misc Annual General Meeting for Curis Inc
05/08/2014 09:00 EDT Misc Curis Inc 1Q2014 Earning Conference Call
05/08/2014 Earnings Curis Inc 1Q2014 Earning Result
04/07/2014 Misc AGM 2014 for Curis, Inc.
02/20/2014 09:00 EST Misc Q4 2013 Curis Inc Earnings Conference Call
02/20/2014 Earnings Q4 2013 Curis Inc Earnings Results
11/06/2013 08:30 EDT Misc Q3 2013 Curis Inc Earnings Conference Call
11/06/2013 Earnings Curis Reports Third Quarter 2013 Financial Results and Provides Cudc-427 Development Update
View All Performance Charts

CRIS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Curis is down 56.78% over the last year vs S&P 500 Total Return up 22.18%, Actelion up 72.08%, and Biogen Idec up 67.18%.

Get Quote for
Advertisement

Portfolio Strategies Featuring CRIS

Did Curis make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CRIS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.curis.com
  • IR Website: http://investors.curis.com/
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.

CRIS Excel Add-In Codes

  • Name: =YCI("CRIS","name")
  • Description: =YCI("CRIS","description")
  • Sector: =YCI("CRIS","sector")
  • Industry: =YCI("CRIS","industry")
  • Est. Current Fiscal Year End: =YCI("CRIS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.